Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease

Background: Myeloperoxidase (MPO) and advanced oxidation protein products, or AOPP (a type of MPO-derived chlorinated adducts), have been implicated in Parkinson´s disease (PD). Human MPO also show sex-based differences in PD. The objective was to study the relationship of MPO and AOPP in the cerebr...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca, Ana Luisa Gavito, Antonio Córdoba-Fernández, José Chacón, Ángel Martín de Pablos
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	myeloperoxidase advanced oxidation protein products cerebrospinal fluid Parkinson’s disease duration
Online Access:	https://www.mdpi.com/2076-3921/11/6/1088

Similar Items

Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis
by: Emilie Rugemalira, et al.
Published: (2019-10-01)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
by: Jiewen Qiu, et al.
Published: (2023-08-01)

Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
by: Joaquín Fernández-Irigoyen, et al.
Published: (2021-04-01)

NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson's disease
by: Napissara Boonpraman, et al.
Published: (2023-06-01)

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
by: Michaela Kaiserova, et al.
Published: (2021-01-01)

Effects of Synthetic Short Cationic Antimicrobial Peptides on the Catalytic Activity of Myeloperoxidase, Reducing Its Oxidative Capacity
by: Tatyana V. Vakhrusheva, et al.
Published: (2022-12-01)

The association of myeloperoxidase and SYNTAX score in patients with ST-elevation myocardial infarction
by: Mykola Kopytsya, et al.
Published: (2023-06-01)

Toxoplasma chorioretinitis in primary myeloperoxidase MPO deficiency: A case report
by: D.V. Maltsev, et al.
Published: (2019-08-01)

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
by: Jiewen Qiu, et al.
Published: (2023-01-01)

Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
by: Zeynep Tufekcioglu, et al.
Published: (2023-10-01)

Myeloperoxidase Deficiency: The Secret Under the Flag of Unstained Cell
by: Türkan Patıroğlu, et al.
Published: (2013-06-01)

Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
by: Elena Vacchi, et al.
Published: (2021-02-01)

Corrigendum: Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
by: Jiewen Qiu, et al.
Published: (2024-10-01)

A Bacterial Myeloperoxidase with Antimicrobial Properties
by: Claire Céré, et al.
Published: (2023-05-01)

Characterization of Myeloperoxidase in the Healthy Equine Endometrium
by: Sonia Parrilla Hernández, et al.
Published: (2023-01-01)

Myeloperoxidase: New roles for an old molecule
by: Stanković Sanja, et al.
Published: (2011-01-01)

Discovery and validation of biomarkers for Parkinson’s disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysisResearch in context
by: Sungtaek Oh, et al.
Published: (2025-08-01)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
by: Anna Emdina, et al.
Published: (2022-05-01)

The Utility of Myeloperoxidase Immunostaining to Characterize Immune Deposits in Patients With Crescentic Glomerulonephritis
by: Rachelle Gietzen, et al.
Published: (2025-05-01)

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
by: Madhurima Chatterjee, et al.
Published: (2020-08-01)

The Role of Serum Myeloperoxidase in Prediction of Severe Bronchial Asthma
by: Kamel Hassan, et al.
Published: (2023-06-01)

Challenges in myeloperoxidase quantification: the inadequacies of current colorimetric approaches
by: Ian Jhemes Oliveira Sousa, et al.
Published: (2025-04-01)

Effect of selective circulate exercise traning on serum myeloperoxidase in females
by: زینب عسگری, et al.
Published: (2011-04-01)

Cerebrospinal Fluid Total, Phosphorylated and Oligomeric A-Synuclein in Parkinson’s Disease: A Systematic Review, Meta-Analysis and Meta-Regression Study
by: Ioanna Kapsali, et al.
Published: (2024-10-01)

Reduced cerebrospinal fluid motion in patients with Parkinson’s disease revealed by magnetic resonance imaging with low b-value diffusion weighted imaging
by: Gabriela Pierobon Mays, et al.
Published: (2024-05-01)

Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
by: Takayuki Katayama, et al.
Published: (2020-07-01)

The Use of Neutrophil Elastase and Neutrophil Myeloperoxidase as Biomarker in Hemarthrosis
by: Rusul Qasim Mohammed, et al.
Published: (2024-05-01)

Cerebrospinal Fluid–Basic Concepts Review
by: Natalia Czarniak, et al.
Published: (2023-05-01)

Endothelial Cell Protein Targeting by Myeloperoxidase-Derived 2-Chlorofatty Aldehyde
by: Shubha Shakya, et al.
Published: (2022-05-01)

Role of thiocyanate in the modulation of myeloperoxidase-derived oxidant induced damage to macrophages
by: Chaorui Guo, et al.
Published: (2020-09-01)

Proteomics for Cerebrospinal Fluid Biomarker Identification in Parkinsons Disease: Methods and Critical Aspects
by: Antonio Conti, et al.
Published: (2015-01-01)

Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer’s disease
by: Astrid Mayleth Rivera Antonio, et al.
Published: (2025-12-01)

Effects and mechanism of myeloperoxidase on microglia in the early stage of intracerebral hemorrhage
by: Wei Zuo, et al.
Published: (2022-12-01)

Gray matter, white matter and cerebrospinal fluid abnormalities in Parkinson’s disease: A voxel-based morphometry study
by: Charles Okanda Nyatega, et al.
Published: (2022-10-01)

Myeloperoxidase as a biomarker for intestinal-brain axis dysfunction induced by malnutrition and Cryptosporidium infection in weanling mice
by: Reinaldo B. Oriá, et al.
Published: (2023-05-01)

Myeloperoxidase induces monocyte migration and activation after acute myocardial infarction
by: Vera B.M. Peters, et al.
Published: (2024-04-01)

Myeloperoxidase enhances the migration and invasion of human choriocarcinoma JEG-3 cells
by: Z.N. Mihalic, et al.
Published: (2023-11-01)

Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy
by: Salma A. Rizo-Téllez, et al.
Published: (2022-11-01)

Comparative analysis of the potential effect of phase I therapy on gingival crevicular fluid myeloperoxidase levels in non-diabetic and diabetic patients with periodontitis
by: Hakan Develioğlu, et al.
Published: (2014-02-01)

Myeloperoxidase and Lysozymes as a Pivotal Hallmark of Immunity Status in Rabbits
by: Rafał Hrynkiewicz, et al.
Published: (2020-09-01)